Interview: Mark Yang, Country Manager, Hospira Taiwan
In 2010, you began your last interview with us by mentioning two things: that because of the nature of this affiliate’s portfolio—with only 35% of revenues generated by pharma at…
Address: 18F, 333 DunHua S. Rd., Sec. 2, DaAn District, Taipei 10669, 10669 台北市敦化南路二段333號18樓,Taiwan
Tel: +886 3 3865117
Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™ through the right people and the right products. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions.
The name ‘Hospira’ is derived from the words hospital, spirit, inspire and the Latin word spero, which means hope. It reflects the company’s primary market focus and expresses the hope and optimism that are critical in the healthcare industry.
Hospira focuses mainly on medical devices in the Taiwanese market, but is currently looking to expand its portfolio and increase its offering of generic drugs.
In 2010, you began your last interview with us by mentioning two things: that because of the nature of this affiliate’s portfolio—with only 35% of revenues generated by pharma at…
What is exciting about the Taiwanese market for Hospira today? Hospira is a US-based company, which used to be part of Abbott Laboratories. A major part of the portfolio for…
Tung-Mao Su, chairman of TPMA, highlights the association’s historic significance in cultivating Taiwan’s pharmaceutical industry, its members’ most pressing concerns, and outlines the developments of the company which he leads…
Ting-Kuo Lee, Academician of Academia Sinica and chairman of the Taiwan Nanotechnology Industry Development Association, explains the history and mission of the association to promote Taiwan’s nano sector and gives…
HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique for the production of mesenchymal stem cells (MSC). Chen then…
Katie Lai, associate director of Medpace Taiwan, introduces the company’s history in Taiwan and highlights the CRO’s unique service offering as a partner of choice to the biotech sector. Lai…
Taiwan boasts a booming life sciences sector and is striving to innovate through collaboration. Here we present five of the key executives and stakeholders who are aiming to drive the…
Albert Lu (founder) and Helen Chiu (co-founder) of Tripod Nano Technology (TPNT), introduce the concept of the original innovative manufacturer (OIM) of metal nanoparticle colloidal solutions and highlight the company’s…
Dr Wen-je Ko, mayor of Taipei City, discusses his plans for creating a key biocluster in the city and goes on to share his views on the government’s role to…
Dr Chien-Huang Lin, tenth president of Taipei Medical University, shares his personal mission upon taking the role, elaborates on the research strengths of TMU, and goes on to discuss the…
Dr Fu-Tong Liu, vice president of Academia Sinica, introduces the institution and its research mission of promoting basic research and enhancing translation. Dr Liu goes on to describe Academia Sinica’s…
Betty Li, managing director of PPC, a well-positioned leader in the APAC CRO landscape, speaks about the strategic significance of the group’s Taiwan affiliate and goes on to share her…
Lily Wu, CEO of PapiVax, discusses the biotechs initiative pipeline for the treatment of HPV related diseases and cancers and goes on to elaborate the company’s development and future partnership…
Luke Chen, co-founder and CEO of PuriBlood, speaks about the innovative spin-off technology developed at the R&D Center for Membrane Technology at Chung Yuan Christian University. The company’s leukocyte reduction…
See our Cookie Privacy Policy Here